← Back to Clinical Trials
Recruiting NCT06643403

NCT06643403 Age-related Changes in Retinal Oxygen Extraction in Healthy Subjects

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06643403
Status Recruiting
Phase
Sponsor Medical University of Vienna
Condition Healthy Participants
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2024-09-30
Primary Completion 2025-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
Oxygen 100% Gas for Inhalation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2024-09-30 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

It has been found that several systemic and ocular diseases are associated with impaired retinal oxygen extraction. In the present study, retinal oxygen extraction will be measured in different age groups in order to identify age related changes in otherwise healthy subjects. In addition, the study will explore short-term changes in retinal metabolism induced by breathing pure oxygen. Measurements will be performed with dynamic vessel analyzer and laser speckle flowgraphy to evaluate retinal blood flow and retinal oxygen saturation, in order to calculate retinal oxygen extraction.

Eligibility Criteria

Inclusion Criteria: * Men and women aged between 18 and 80 years * Signed informed consent * Normal ophthalmic findings, unless the investigator considers an abnormality to be clinically irrelevant for the purpose of the study * Normal findings in the medical history, unless the investigator considers an abnormality to be clinically irrelevant for the purpose of the study * Nonsmokers Exclusion Criteria: * Abuse of alcoholic beverages or drugs * Participation in a clinical trial in the 3 weeks preceding the study * Symptoms of a clinically relevant illness in the 3 weeks before the first study day * Blood donation during the previous 3 weeks * Pregnant or breast-feeding women

Contact & Investigator

Central Contact

Doreen Schmidl-Schordje, MD

✉ doreen.schmidl@meduniwien.ac.at

📞 +43 1 40400

Frequently Asked Questions

Who can join the NCT06643403 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Healthy Participants. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06643403 currently recruiting?

Yes, NCT06643403 is actively recruiting participants. Contact the research team at doreen.schmidl@meduniwien.ac.at for enrollment information.

Where is the NCT06643403 trial being conducted?

This trial is being conducted at Vienna, Austria.

Who is sponsoring the NCT06643403 clinical trial?

NCT06643403 is sponsored by Medical University of Vienna. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology